BHC
$9.25
2.436%
Bausch Health Companies Inc.News & Events
Last updated: Jul 24, 2025, 11:35 PM ET
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors
ACCESS Newswire JUL 24, 2025 8:02 AM EDTLAVAL, QC / ACCESS Newswire / July 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)...READ ARTICLECORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs
ACCESS Newswire JUL 10, 2025 5:00 PM EDTThis press release updates the headline of the previously posted release LAVAL, QC / ACCESS...READ ARTICLEBausch Health Appoints New Chief Accounting Officer
ACCESS Newswire JUL 10, 2025 4:15 PM EDTLAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)...READ ARTICLEBausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs
ACCESS Newswire JUL 9, 2025 8:00 AM EDTLAVAL, QC / ACCESS Newswire / July 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health...READ ARTICLEBausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence
ACCESS Newswire JUL 7, 2025 8:00 AM EDTFocused on highlighting real patient experiences, Salix continues to lead the charge in educating...READ ARTICLEBausch Health to Announce Second Quarter 2025 Results on July 30
ACCESS Newswire JUL 2, 2025 7:00 AM EDTLAVAL, QC / ACCESS Newswire / July 2, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ...READ ARTICLEBausch Health Announces 2025 Annual Meeting of Shareholder Results
ACCESS Newswire MAY 14, 2025 4:15 PM EDTLAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ...READ ARTICLEXifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
ACCESS Newswire MAY 6, 2025 8:00 AM EDTNew analysis suggests efficacy of Xifaxan to mitigate OHE rehospitalizations irrespective of trea...READ ARTICLEBausch Health Announces First Quarter 2025 Results
ACCESS Newswire APR 30, 2025 4:05 PM EDTFirst Quarter Consolidated Revenues of $2.26 billion, up 5% on a Reported basis and 6% on an Orga...READ ARTICLEBausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System
ACCESS Newswire APR 29, 2025 8:00 AM EDTA Long-Awaited Advancement in Non-Invasive Radiofrequency Skin Tightening Is Now Approved for the...READ ARTICLE